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Humanity incorporates obvious ideas with diffi culty 
and therefore slowly. But there is no doubt that this will 
be the century of technological evaluations in the fi eld of 
health. How can tests and products for which effectiveness, 
effi ciency and safety have not been demonstrated be incor-
porated into our diagnostic and therapeutic procedures? 
As you well know, dear reader, this is still done openly, 
which cannot be anything other than irresponsibility. In 
this equation, life does not necessarily come in fi rst place! 
In fact, it is high time for this easily understood matter to 
be taken on board: life comes in fi rst place. 
But going back to technological evaluations, my 
question would be: who is it up to, to prove that a new 
car works (effi cacy), works well in the places you go to 
(effectiveness), is economical and easy to maintain (ef-
fi ciency) and is safe? Clearly, you are not going to pay 
to check on this: companies test their cars because they 
prefer to avoid greater problems with their consumers, 
and in particular with the law. Interestingly, the same 
thing does not take place in the fi eld of health. Products 
are launched, sometimes at most on the basis of small 
clinical trials, and it is up to consumers to risk their health 
through medical prescriptions, to see whether the new 
item works or not. 
However, this is the role of controlled clinical trials 
and the systematic reviews that sum them when they 
are similar and of good quality, in order to reduce the 
uncertainties in the questions of efficiency and safety. 
In the field of health, the consumer maxim “satisfac-
tion guaranteed (cure) or your money (or life) back!” 
has no validity.
Recent history has demonstrated that the require-
ments of the United States Food and Drug Administra-
tion (FDA) have been insuffi cient to ensure that new 
products would cause more benefi ts than harm. Thus, 
it will be necessary for technological evaluations within 
the fi eld of health to be developed and start to form 
part of the scientifi c activities in this fi eld. Theoretical 
hypotheses in the era of the logic based on physiopa-
thology need to be left behind for the era of logic that is 
proven or refuted by evidence. This will require an era of 
technological evaluations within the fi eld of health that 
are based on reliable scientifi c evidence.
From October 23 to 28, 2007, the World Colloquium 
of the Cochrane Collaboration will take place in São Paulo. 
Researchers from more than 70 countries will discuss how 
to move towards “Evidence-based health for all”. This 
theme was chosen to run alongside “Outcomes (results) 
based on patients’ preferences”. 
Who is it of interest to, that new technologies are eva-
luated on the basis of evidence? Firstly, people who have 
health problems (do you know anyone like this?). It is also 
of interest to people who wish to preserve their health. It is of 
interest to health professionals, healthcare resource providers, 
health policy planners, Health Departments and the Ministry 
of Health, healthcare companies, health sector industries, 
prosecutors, attorneys, judges, and thus everyone who is 
seriously involved with their own health, the health of their 
nearest and dearest, and the health of society as a whole.
It should also be pointed out that the activities of 
the Cochrane Collaboration must be independent of the 
interests of companies that aim to make profi ts coming 
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from the fi eld of health, so that it can retain 
its impartiality. For a long time, our col-
leagues and the entities that represent them 
have been calling for independent scientifi c 
activities without confl icts of interest. The 
Colloquium does not accept sponsorship 
from such companies, not because it does 
not consider them to have a very important 
role, but to be able to be in a position to 
critically evaluate their products. The 
search for effi ciency and safety within the 
fi eld of health is also of interest with regard 
to maintaining a healthy consumer market 
for all participants. 
The Colloquium is being organized by 
the Brazilian Cochrane Center and by the 
Regional Library of Medicine (Biblioteca 
Regional de Medicina, BIREME). Make a 
date in your diary for the Cochrane Col-
loquium in São Paulo, from October 23 to 
27, 2007 (www.centrocochranedobrasil.
org.br, www.colloquiumbrasil.info).
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